Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTEN F KUTZ

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1629138813
CMS profile
10683993
Location
COLORADO SPRINGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$191,690.32

460 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 7 of 10; records 301–350 of 460 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTEN F KUTZ

NPI 1629138813 · CMS profile ID 10683993

Physician Assistants & Advanced Practice Nursing Providers / Physician Assistant / Medical

COLORADO SPRINGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 7 of 10; records 301–350 of 460 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629138813?year=2025&recipient=provider&page=7#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTEN F KUTZ, NPI 1629138813, CMS profile ID 10683993. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 10; records 301–350 of 460 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629138813?year=2025&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). CHRISTEN F KUTZ, NPI 1629138813, CMS profile ID 10683993. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 10; records 301–350 of 460 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629138813?year=2025&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
CHRISTEN F KUTZ, NPI 1629138813, CMS profile ID 10683993, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 7 of 10; records 301–350 of 460 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1629138813?year=2025&recipient=provider&page=7#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

460 matching records · $191,690.32 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 460 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 301–350 of 460.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $4.4504/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200209236 CMS
Novartis Pharmaceuticals Corporation $2.5004/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200209238 CMS
PFIZER INC. $25.3604/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229214925 CMS
PFIZER INC. $13.4304/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229609247 CMS
TG Therapeutics, Inc. $132.9904/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226250971 CMS
TG Therapeutics, Inc. $3,240.0004/26/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226251007 CMS
TG Therapeutics, Inc. $26.8304/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226251173 CMS
TG Therapeutics, Inc. $12.4404/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226251181 CMS
TG Therapeutics, Inc. $50.6804/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226251193 CMS
TG Therapeutics, Inc. $370.9704/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226251048 CMS
TG Therapeutics, Inc. $104.9004/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226251165 CMS
TG Therapeutics, Inc. $315.5304/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226251201 CMS
Novartis Pharmaceuticals Corporation $5.4604/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200209230 CMS
TG Therapeutics, Inc. $7.1404/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226250945 CMS
TG Therapeutics, Inc. $28.1404/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226250949 CMS
UCB, Inc. $122.8904/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224778010 CMS
UCB, Inc. $13.8004/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224778008 CMS
ANI Pharmaceuticals, Inc. $17.7404/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248663615 CMS
Mallinckrodt Hospital Products Inc. $14.2004/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212020572 CMS
Novartis Pharmaceuticals Corporation $4.2504/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200209232 CMS
Vanda Pharmaceuticals Inc. $122.4204/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233081687 CMS
Vanda Pharmaceuticals Inc. $4,313.0004/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233081689 CMS
Vanda Pharmaceuticals Inc. $387.9604/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233081691 CMS
Vanda Pharmaceuticals Inc. $215.4804/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233081693 CMS
Vanda Pharmaceuticals Inc. $571.9804/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233081695 CMS
Vanda Pharmaceuticals Inc. $17.6004/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233081697 CMS
Biogen, Inc. $105.4804/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208311131 CMS
Biogen, Inc. $22.6504/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208450663 CMS
Novartis Pharmaceuticals Corporation $6.6704/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200209234 CMS
Novartis Pharmaceuticals Corporation $5.6804/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200209250 CMS
Biogen, Inc. $112.0004/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1208348371 CMS
Biogen, Inc. $2,616.0004/15/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1208460775 CMS
Vanda Pharmaceuticals Inc. $10.5704/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233081685 CMS
TG Therapeutics, Inc. $30.0504/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226251056 CMS
ACADIA Pharmaceuticals Inc $17.6304/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247817766 CMS
UCB, Inc. $10.1804/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224778006 CMS
Janssen Scientific Affairs, LLC $59.6304/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174155229 CMS
LivaNova USA, Inc. $27.0404/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245674670 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,035.0004/09/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1223793737 CMS
TG Therapeutics, Inc. $2,447.5004/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226251026 CMS
TG Therapeutics, Inc. $28.0004/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226251041 CMS
Lilly USA, LLC $17.6604/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187094872 CMS
EMD Serono, Inc. $31.5004/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236873664 CMS
EMD Serono, Inc. $74.9904/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236900709 CMS
EMD Serono, Inc. $89.9904/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236919080 CMS
ABBVIE INC. $6.1904/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204617240 CMS
ARGENX US, INC. $17.3304/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240423796 CMS
Abbott Laboratories $139.5904/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240720706 CMS
EMD Serono, Inc. $319.2604/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236900797 CMS
EMD Serono, Inc. $143.2004/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236901926 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $111,641.13 346
PY2022 $105,437.54 336
PY2023 $92,596.59 345
PY2024 $108,320.18 352
PY2025 $191,690.32 460

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $569,506.58 27
PY2024 Principal investigator $482,223.27 25
PY2023 Recipient $19,775.00 3
PY2023 Principal investigator $296,655.49 43
PY2022 Principal investigator $140,946.40 16
PY2021 Recipient $5,814.59 2
PY2021 Principal investigator $290,542.63 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 TG Therapeutics, Inc. $75.00 12/23/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200902
Principal investigator 1 TG Therapeutics, Inc. $100.00 12/11/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200900
Principal investigator 1 TG Therapeutics, Inc. $50.00 12/03/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200898
Principal investigator 1 TG Therapeutics, Inc. $5,840.00 11/30/2025 Non-covered Recipient Entity
Research of the Rockies, LLC
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200405
Principal investigator 1 TG Therapeutics, Inc. $43,975.00 11/30/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200888
Principal investigator 1 TG Therapeutics, Inc. $50.00 11/18/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200896
Principal investigator 1 TG Therapeutics, Inc. $100.00 11/06/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200894
Principal investigator 1 TG Therapeutics, Inc. $23,750.00 11/01/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200886
Principal investigator 1 TG Therapeutics, Inc. $100.00 10/23/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200892
Principal investigator 1 TG Therapeutics, Inc. $125.00 10/07/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200890
Principal investigator 1 TG Therapeutics, Inc. $41,550.00 10/01/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200882
Principal investigator 1 TG Therapeutics, Inc. $34,975.00 10/01/2025 Non-covered Recipient Entity
CSNA
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200884
Principal investigator 1 TG Therapeutics, Inc. $41,550.00 09/30/2025 Non-covered Recipient Entity
Research Center of Southern CaliforniaLLC
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200403
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $24,242.00 09/27/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN RESEARCH AND CONSULTING
Retrospective analysis of Intravenous immunoglobulin (IVIG) infusion switches to immune globulin infusion 10% with recombinant human hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) No dispute reported 06/30/2026 1223286005
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $11,000.00 09/26/2025 Non-covered Recipient Entity
Research Of The Rockies
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Agitation Associated with Alzheimers Disease No dispute reported 06/30/2026 1235994249
Principal investigator 1 TG Therapeutics, Inc. $34,975.00 08/31/2025 Non-covered Recipient Entity
Research Center of Southern CaliforniaLLC
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study No dispute reported 06/30/2026 1226200401
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $24,242.00 08/09/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN RESEARCH AND CONSULTING
Retrospective analysis of Intravenous immunoglobulin (IVIG) infusion switches to immune globulin infusion 10% with recombinant human hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) No dispute reported 06/30/2026 1223283989
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $93,350.00 07/18/2025 Non-covered Recipient Entity
Rocky Mountain Research And Consulting
Retrospective analysis of RW treatment with KarXT in schizophrenia No dispute reported 06/30/2026 1235994151
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,122.70 06/25/2025 Non-covered Recipient Entity
Colorado Springs Neurological Associates, PC
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Agitation Associated with Alzheimers Disease No dispute reported 06/30/2026 1235997920
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $24,242.00 05/15/2025 Non-covered Recipient Entity
ROCKY MOUNTAIN RESEARCH AND CONSULTING
Retrospective analysis of Intravenous immunoglobulin (IVIG) infusion switches to immune globulin infusion 10% with recombinant human hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) No dispute reported 06/30/2026 1223279852
Principal investigator 1 Eli Lilly and Company $388.00 04/01/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES
PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) No dispute reported 06/30/2026 1187880119
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $145,100.00 02/03/2025 Non-covered Recipient Entity
Rocky Mountain Research And Consulting
Retrospective analysis of the efficacy, safety, and tolerability outcomes after CD20-directed cytolytic antibody treatment switches to ozanimod in patients with relapsing multiple sclerosis (MS) No dispute reported 06/30/2026 1235994149
Principal investigator 1 Roche Products Limited $285.24 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590064
Principal investigator 1 Roche Products Limited $171.16 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590069
Principal investigator 1 Roche Products Limited $285.24 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590072
Principal investigator 1 Roche Products Limited $285.24 01/09/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES PC
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211590077
Principal investigator 1 Eli Lilly and Company $17,578.00 01/07/2025 Non-covered Recipient Entity
COLORADO SPRINGS NEUROLOGICAL ASSOCIATES
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187878597